Found 13 matching trials
Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis PHASE3 Palmoplantar pustulosis (PPP) is a rare, chronic inflammatory skin disease ...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis PHASE2 There are cells in the skin and blood of humans with chronic moderate to se...
Show More Location
Dermatology Research Associates
Learn More & Join Trial
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis PHASE2 This study has been designed to explore the clinical efficacy and safety of...
Show More Location
Huashan Hospital affiliated to Fudan University
Learn More & Join Trial
Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA) PHASE2 Evaluation of efficacy and safety of tofacitinib (CP-690,550) for the treat...
Show More Location
ArthroCare, Arthritis Care & Research, PC
Learn More & Join Trial
Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment PHASE2 The primary objective of the study is to evaluate the effect of GS-5718 ver...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis PHASE3 This is a 6 month study investigating the effectiveness and safety of tofac...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) PHASE3 This study \[contRAst 2 (201791: NCT03970837)\] is a phase 3, randomized, m...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors PHASE3 To examine the safety and efficacy of tofacitinib in subjects with active p...
Show More Location
Rheumatology Associates P.C.
Learn More & Join Trial
Efficacy Study Of Tofacitinib In Pediatric JIA Population PHASE3 Evaluate efficacy, safety and tolerability of tofacitinib in pediatric JIA ...
Show More Location
Arkansas Children's Hospital - Attention: Jill Hernandez
Learn More & Join Trial
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis PHASE4 This study is designed to evaluate the efficacy and safety of tofacitinib m...
Show More Location
Rheumatology Associates of North Alabama, PC
Learn More & Join Trial